AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20156053 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy exercise group (EG) - short-term supervised inpatient physiotherapy exercise protocol including early mobilisation with progressive exercises plus usual care (respiratory exercises)
Number of subjects: 74
Study 20156053 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy usual care group (UCG) - only received respiratory exercises
Number of subjects: 74
Study 18754530 — intervention group
Group type: EXPERIMENTAL
Intervention: Myasthenic subjects
Number of subjects: 32
Study 18754530 — intervention group
Group type: COMPARATOR
Intervention: Non-Myasthenic subjects
Number of subjects: 32
Study 15939311 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg once daily (o.d.)
Number of subjects: 26
Study 15939311 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 640 microg once daily (o.d.)
Number of subjects: 26
Study 15939311 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 640 microg twice daily (b.i.d.)
Number of subjects: 26
Study 15939311 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 440 microg twice daily (b.i.d.)
Number of subjects: 26
Study 15939311 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 880 microg twice daily (b.i.d.)
Number of subjects: 26
Study 15939311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 14568851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor treatment
Number of subjects: 36
Study 14568851 — intervention group
Group type: COMPARATOR
Intervention: Conventional topical treatment
Number of subjects: 36
Study 10930151 — intervention group
Group type: EXPERIMENTAL
Intervention: ALVAC‐HIV followed by the protein vaccine
Number of subjects: 0
Study 8653191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost recovery intervention with improved drug supply in Say and Boboye
Number of subjects: 3
Study 8653191 — intervention group
Group type: COMPARATOR
Intervention: Control site (Illela)
Number of subjects: 3
Study 8653191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost recovery intervention in Say
Number of subjects: 3
Study 8653191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost recovery intervention in Boboye
Number of subjects: 3
Study 1900335 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN)
Number of subjects: 72
Study 1900335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 6387977 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound stimulation
Number of subjects: 40
Study 6387977 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote stimulation
Number of subjects: 40
Study 6387977 — intervention group
Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 40
Study 6387977 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound stimulation and remote stimulation
Number of subjects: 40
Study 31663569 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoghurt enriched with vitamins B1, B5 and B6 (VY)
Number of subjects: 33
Study 31663569 — intervention group
Group type: COMPARATOR
Intervention: Conventional yoghurt (CY)
Number of subjects: 33
Study 31340132 — intervention group
Group type: EXPERIMENTAL
Intervention: Barium sulfate with sodium bicarbonate granules
Number of subjects: 42
Study 31340132 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated water
Number of subjects: 42
Study 31340132 — intervention group
Group type: EXPERIMENTAL
Intervention: Barium sulfate with carbonated water
Number of subjects: 42
Study 31340132 — intervention group
Group type: EXPERIMENTAL
Intervention: Water
Number of subjects: 42
Study 28938876 — intervention group
Group type: EXPERIMENTAL
Intervention: Larval source management (LSM) and house improvement (HI) as additional interventions to standard malaria control strategies.
Number of subjects: 25000
Study 28938876 — intervention group
Group type: COMPARATOR
Intervention: Standard malaria control strategies (LLINs and IRS).
Number of subjects: 25000
Study 25150159 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 units · mL(‐1) (Gla‐300) at 0.4 units · kg(‐1)
Number of subjects: 30
Study 25150159 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 100 units · mL(‐1) (Gla‐100) at 0.4 units · kg(‐1)
Number of subjects: 30
Study 24511720 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl 1 microg/kg
Number of subjects: 144
Study 24511720 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 1 ml/10 kg
Number of subjects: 144
Study 21680653 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated volumetry (ABV)
Number of subjects: 70
Study 21680653 — intervention group
Group type: COMPARATOR
Intervention: Manual volumetry
Number of subjects: 70
Study 18566109 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher tidal volume ventilation
Number of subjects: 676
Study 18566109 — intervention group
Group type: COMPARATOR
Intervention: Lower tidal volume ventilation
Number of subjects: 676
Study 16864830 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined IV-intra-arterial thrombolysis
Number of subjects: 0
Study 16864830 — intervention group
Group type: COMPARATOR
Intervention: IV thrombolysis
Number of subjects: 0
Study 12838218 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 L of polyethylene glycol-electrolyte solution, one tablet of bisacodyl, and a minimally restricted diet on the day before colonoscopy, and then 1 L of the same solution on the day of colonoscopy (Group B)
Number of subjects: 187
Study 12838218 — intervention group
Group type: COMPARATOR
Intervention: 3 L of polyethylene glycol-electrolyte solution with a liquid diet on the day before colonoscopy (Group A)
Number of subjects: 187
Study 12838218 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 187
Study 10834779 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA with 0.1% bupivacaine + fentanyl (3 microg/mL) at 5 mL/h
Number of subjects: 40
Study 9118706 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP System 12/4
Number of subjects: 33
Study 9118706 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP System 8/4
Number of subjects: 33
Study 9118706 — intervention group
Group type: COMPARATOR
Intervention: O2 via a face mask
Number of subjects: 33
Study 8436747 — intervention group
Group type: EXPERIMENTAL
Intervention: Zofenopril (angiotensin-converting enzyme inhibitor)
Number of subjects: 13
Study 8436747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 3017605 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg b.d.)
Number of subjects: 12
Study 3017605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31468364 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement (0% 'habitual bite', 25%, 50%, 75%, 100% of maximum mandibular advancement)
Number of subjects: 17
Study 31468364 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders to MAS therapy
Number of subjects: 17
Study 31468364 — intervention group
Group type: COMPARATOR
Intervention: 0% mandibular advancement
Number of subjects: 17
Study 30577862 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-step physician-driven support during the dying and death process
Number of subjects: 900
Study 30577862 — intervention group
Group type: COMPARATOR
Intervention: Standard of care practice
Number of subjects: 900
Study 27840477 — intervention group
Group type: EXPERIMENTAL
Intervention: Kermanshahi family traditional massage
Number of subjects: 50
Study 27840477 — intervention group
Group type: COMPARATOR
Intervention: Classic treatment (control)
Number of subjects: 50
Study 25222185 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 100 mg
Number of subjects: 54
Study 25222185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 22104366 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years BASIC parenting program
Number of subjects: 33
Study 20825695 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized letters plus an educational booklet (Group A)
Number of subjects: 150
Study 20825695 — intervention group
Group type: COMPARATOR
Intervention: Personalized letters only (Group B)
Number of subjects: 150
Study 18257180 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild-warm moxibustion
Number of subjects: 60
Study 18257180 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 60
Study 18257180 — intervention group
Group type: COMPARATOR
Intervention: Medication (Mecobalamin tablets)
Number of subjects: 60
Study 15927394 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/d
Number of subjects: 457
Study 15927394 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 120 mg/d
Number of subjects: 457
Study 15927394 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (all active treatment groups)
Number of subjects: 457
Study 15927394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study 12593490 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigvaris Traveno elastic stockings (12-18 mm Hg pressure at the ankle)
Number of subjects: 211
Study 12593490 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 211
Study 12593490 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigvaris Traveno stockings (for flights lasting 11-12 hours)
Number of subjects: 211
Study 12593490 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylaxis for flights lasting 11-12 hours)
Number of subjects: 211
Study 10687907 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 20
Study 10687907 — intervention group
Group type: COMPARATOR
Intervention: Bone Scintigraphy
Number of subjects: 20
Study 8813982 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinolytic therapy
Number of subjects: 50446
Study 1869009 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of positive axillary lymph nodes (0-3 versus 4+)
Number of subjects: 145
Study 1869009 — intervention group
Group type: EXPERIMENTAL
Intervention: Localisation of tumour relapse (local versus visceral metastasis)
Number of subjects: 145
Study 1869009 — intervention group
Group type: EXPERIMENTAL
Intervention: Localisation of tumour relapse (local versus bone metastases)
Number of subjects: 145
Study 6988748 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course group (24 patients) receiving 24 hours of cephalosporin prophylaxis
Number of subjects: 80
Study 6988748 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-course group (25 patients) receiving 5 days of cephalosporin prophylaxis
Number of subjects: 80
Study 6988748 — intervention group
Group type: COMPARATOR
Intervention: Control group (31 patients) receiving no prophylactic antibiotics
Number of subjects: 80
Study 31550091 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative mental health status (measured by SF-36 mental health component)
Number of subjects: 677
Study 31550091 — intervention group
Group type: COMPARATOR
Intervention: Age, obesity, back pain, awaiting another joint arthroplasty operation
Number of subjects: 677
Study 29101130 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced expectancy manipulation and enhanced empathy manipulation
Number of subjects: 128
Study 29101130 — intervention group
Group type: COMPARATOR
Intervention: Standard expectancy manipulation and standard empathy manipulation
Number of subjects: 128
Study 25581505 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the study
Number of subjects: 508
Study 25581505 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivators for continued participation
Number of subjects: 508
Study 25581505 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control treatment strategy
Number of subjects: 508
Study 25581505 — intervention group
Group type: EXPERIMENTAL
Intervention: Good treatment strategy
Number of subjects: 508
Study 25581505 — intervention group
Group type: EXPERIMENTAL
Intervention: Good medication
Number of subjects: 508
Study 25581505 — intervention group
Group type: EXPERIMENTAL
Intervention: Good half-term results
Number of subjects: 508
Study 25581505 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall experience of participation
Number of subjects: 508
Study 25581505 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional examinations during yearly visits
Number of subjects: 508
Study 23674254 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 60
Study 23674254 — intervention group
Group type: COMPARATOR
Intervention: Delayed enteral nutrition (DEN)
Number of subjects: 60
Study 17095194 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 462
Study 17095194 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 462
Study 17095194 — intervention group
Group type: EXPERIMENTAL
Intervention: Remission group
Number of subjects: 462
Study 17095194 — intervention group
Group type: COMPARATOR
Intervention: Non-remission group
Number of subjects: 462
Study 15473387 — intervention group
Group type: EXPERIMENTAL
Intervention: Intruded teeth
Number of subjects: 0
Study 15473387 — intervention group
Group type: COMPARATOR
Intervention: Control teeth
Number of subjects: 0
Study 15473387 — intervention group
Group type: COMPARATOR
Intervention: Test and control teeth
Number of subjects: 0
Study 11294404 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic GBP
Number of subjects: 70
Study 11294404 — intervention group
Group type: COMPARATOR
Intervention: Open GBP
Number of subjects: 70
Study 9085316 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin 1000 mg infused during the last hour of hemodialysis with cellulose triacetate (CT) hemodialyzer
Number of subjects: 8
Study 9085316 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin 1000 mg infused during the last hour of hemodialysis with cellulose acetate (CA) hemodialyzer
Number of subjects: 8
Study 9085316 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin 1000 mg infused after dialysis was completed (control)
Number of subjects: 8
Study 7506181 — intervention group
Group type: EXPERIMENTAL
Intervention: nimesulide
Number of subjects: 35
Study 7506181 — intervention group
Group type: COMPARATOR
Intervention: paracetamol
Number of subjects: 35
Study 3566858 — intervention group
Group type: COMPARATOR
Intervention: Fendiline hydrochloride 200 mg, 400 mg, 600 mg, 800 mg, 1000 mg, 1200 mg (single doses)
Number of subjects: 27
Study 3566858 — intervention group
Group type: COMPARATOR
Intervention: Fendiline hydrochloride 400 mg twice daily (initially), reduced to 200 mg twice daily after 5 days due to intolerability
Number of subjects: 27
Study 3566858 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 subjects per dose level in the first study and 3 subjects in the second study)
Number of subjects: 27
Study 30716528 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent recorded ECGs (1290 newborns)
Number of subjects: 2582
Study 30716528 — intervention group
Group type: COMPARATOR
Intervention: Staff recorded ECGs (1292 newborns)
Number of subjects: 2582
Study 29631857 — intervention group
Group type: EXPERIMENTAL
Intervention: aIIV4
Number of subjects: 10612
Study 27959613 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus letrozole
Number of subjects: 666
Study 27959613 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 666
Study 25210629 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive care
Number of subjects: 150
Study 25210629 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure (BL32 acupoint)
Number of subjects: 150
Study 25210629 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study 22215022 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic conditioning (group A)
Number of subjects: 41
Study 22215022 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional strength training (group B)
Number of subjects: 41
Study 21178939 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program (12 weeks, aerobic training, strength, and flexibility exercises, 3 times/week)
Number of subjects: 27
Study 21178939 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 27
Study 17950835 — intervention group
Group type: EXPERIMENTAL
Intervention: Endeavor zotarolimus‐eluting stent (ZES)
Number of subjects: 0
Study 17950835 — intervention group
Group type: COMPARATOR
Intervention: Driver bare metal stent (BMS)
Number of subjects: 0
Study 17950835 — intervention group
Group type: COMPARATOR
Intervention: First‐generation Cypher sirolimus‐eluting stent (SES)
Number of subjects: 0
Study 17950835 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel‐eluting stent (PES)
Number of subjects: 0
Study 15766375 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% CHX non-alcohol base with 0.05% cetyl pyridinium chloride (Cpc) mouthrinse (Perioaid), 15 ml, twice daily for 30 s
Number of subjects: 40
Study 15766375 — intervention group
Group type: COMPARATOR
Intervention: 0.2% CHX alcohol base (Corsodyl), 10 ml, twice daily for 60 s
Number of subjects: 40
Study 15766375 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% CHX non-alcohol base with 0.05% cetyl pyridinium chloride (Cpc) mouthrinse (Perioaid)
Number of subjects: 40
Study 15766375 — intervention group
Group type: COMPARATOR
Intervention: 0.2% CHX alcohol base (Corsodyl)
Number of subjects: 40
Study 11982617 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 1 mg/kg/dose every 14 d for five doses (Group I)
Number of subjects: 166
Study 11982617 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 2 mg/kg/dose every 14 d for two doses (Group II)
Number of subjects: 166
Study 11982617 — intervention group
Group type: COMPARATOR
Intervention: No antibody induction (Group III)
Number of subjects: 166
Study 10459562 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity aerobic training (50% estimated VO2max for 60 minutes, 2-4 times per week for 5 months)
Number of subjects: 20
Study 10459562 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physical training)
Number of subjects: 20
Study 7598117 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal occult blood screening intervention
Number of subjects: 15476
Study 7598117 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic colorectal examination (negative results)
Number of subjects: 15476
Study 2113567 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotropin‐releasing hormone (TRH) (200 micrograms iv)
Number of subjects: 10
Study 2113567 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐desamino‐8‐D‐arginine vasopressin (DDAVP) (4 micrograms iv)
Number of subjects: 10
Study 2113567 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine HCl (Apo) (0.5 mg sc)
Number of subjects: 10
Study 2113567 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP plus Apo
Number of subjects: 10
Study 2113567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 37871 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 25
Study 37871 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 25
Study 37871 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 25
Study 37871 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 25
Study 37871 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 25
Study 37871 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 25
Study 31124887 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg i.v. dexamethasone
Number of subjects: 98
Study 31124887 — intervention group
Group type: COMPARATOR
Intervention: 2 cm i.v. 0.9% saline (Control)
Number of subjects: 98
Study 27978548 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (1000 IU)
Number of subjects: 2259
Study 27978548 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation (1200 mg elemental calcium)
Number of subjects: 2259
Study 25874636 — intervention group
Group type: EXPERIMENTAL
Intervention: Three fatty fish meals per week
Number of subjects: 106
Study 25874636 — intervention group
Group type: COMPARATOR
Intervention: Habitual fish consumption
Number of subjects: 106
Study 25874636 — intervention group
Group type: COMPARATOR
Intervention: Maximum of one fish meal per week
Number of subjects: 106
Study 23691925 — intervention group
Group type: EXPERIMENTAL
Intervention: Family group psychotherapy (FGP) - 8 monthly sessions
Number of subjects: 17
Study 23691925 — intervention group
Group type: COMPARATOR
Intervention: Control group (no psychotherapy)
Number of subjects: 17
Study 23691925 — intervention group
Group type: EXPERIMENTAL
Intervention: Family group psychotherapy (FGP)
Number of subjects: 17
Study 21316980 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital device for AL measurement (Drentech PALM)
Number of subjects: 49
Study 18672332 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel
Number of subjects: 38
Study 18672332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 17355744 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (160 mg)
Number of subjects: 18
Study 17355744 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg)
Number of subjects: 18
Study 17355744 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of valsartan (160 mg) and simvastatin (40 mg)
Number of subjects: 18
Study 15287311 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 64
Study 15287311 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac 30 mg
Number of subjects: 64
Study 11517998 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) injections into the calf muscles
Number of subjects: 10
Study 11517998 — intervention group
Group type: COMPARATOR
Intervention: Saline injections (single blind control)
Number of subjects: 10
Study 9605054 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial shock of 1.5 J/kg based on body weight
Number of subjects: 39
Study 8139380 — intervention group
Group type: EXPERIMENTAL
Intervention: IV scopolamine
Number of subjects: 22
Study 8139380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 3262334 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin plus electric stimulation
Number of subjects: 48